Enaltus (US rights to BioCorneum) Overview

  • Status

  • Acquired/​Merged

  • Latest Deal Type

  • Asset Purch.

  • Financing Rounds

  • 1

Enaltus (US rights to BioCorneum) General Information

Description

Rights of a pharmaceutical product. The asset includes distribution rights for BioCorneum, an advanced silicone gel scar management products in the United States. The product is a quick drying, patented silicone gel that creates an invisible, breathable, flexible and waterproof silicone sheet over scars.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Sientra
Primary Office
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enaltus (US rights to BioCorneum) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Enaltus (US rights to BioCorneum)‘s full profile, request access.

Request a free trial

Enaltus (US rights to BioCorneum) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Enaltus (US rights to BioCorneum)‘s full profile, request access.

Request a free trial